
Indian drugmakers expand semaglutide battle overseas
The story in brief
Indian drugmakers are expanding the generic semaglutide battle overseas, with Hetero exporting to Africa, Asia and the Middle East, Lupin partnering with Spain's Galenicum, and Dr Reddy's securing Brazil approval. Sales rose to Rs 113 crore, while domestic volumes grew 88% in April before easing. South Africa is reviewing 12 generic applications.